End-of-day scoring · Prices as of last close
Educational Analytics — No Financial Advice
Scanning 9,000+ Stocks & Crypto
_
Elicio Therapeutics Inc
Elicio Therapeutics develops cancer vaccines that work by training the body's immune system to recognize and attack tumor cells. These vaccines are designed for cancer patients who need treatments that specifically target their disease. The company makes money through research grants, partnerships with larger pharmaceutical companies, and potentially from future sales if their treatments receive regulatory approval and reach the market.
The biotechnology industry focuses on developing medical treatments using biological systems. Companies in this space often work on innovative therapies like cancer vaccines, which aim to harness the body's immune system to fight diseases. These companies typically rely on research funding and partnerships before generating revenue from approved treatments.
Intelligence Pipeline Active
ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.
No active score modifiers detected
Price is overextended from the 20-day trend lead.
Large opening gap indicates potential short-term exhaustion.
Price is extended significantly above 52-week highs.
Banana Farmer tracks 100's of signals to synthesize this proprietary score.
Our engine is currently indexing ELTX across global social channels to detect early sentiment shifts and technical alignment.
Intelligence Narrative Connected
Educational only. Not investment advice.
Loading chart...
Loading chart...
Loading chart...
Loading chart...